In this episode, we cover President Trump’s recent pharmacy executive order aimed at lowering U.S. drug prices. With employers feeling the weight of pharmacy spend—and the U.S. covering the bulk of global pharmaceutical costs— could this move prompt bipartisan legislation that results in lasting change?

We also examine the “Big Beautiful Bill”, which includes Medicaid work requirements, expanded HSA access, and new employer incentives to support individual market coverage. Don’t miss this conversation!